As of 1:30 PM on the 6th, Komipharm is trading at 13,000 KRW, down 2.99% from the previous day. This represents a 15.03% decline compared to October 12. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.

Today, foreigners have net sold 26,897 shares of Komipharm, while institutions have net bought 2,000 shares, according to provisional data. Over the past five days, individual investors have net sold 237,294 shares, while foreigners and institutions have net bought 158,818 shares and 77,504 shares, respectively.


On October 27, Komipharm became a market issue with the headline, "New drug 'Kominox anticancer effect' confirmed?... Stock price rebounds."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing